Ihor Karpenko

Recent publications · Crossref

5 total works indexed

1. Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

   · 2008 · cited 3,144x

2. Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

   · 2019 · cited 2,920x

3. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

   · 2019 · cited 2,824x

4. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

   · 2019 · cited 2,777x

5. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

   · 2019 · cited 1,863x

via Crossref · CC0